Bank of America Increases Teladoc Health (NYSE:TDOC) Price Target to $13.50

Teladoc Health (NYSE:TDOC) had its price objective increased by equities researchers at Bank of America from $11.50 to $13.50 in a report released on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the health services provider’s stock. Bank of America‘s price target indicates a potential upside of 3.89% from the company’s current price.

A number of other equities analysts have also weighed in on TDOC. Deutsche Bank Aktiengesellschaft upped their price objective on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. Royal Bank of Canada upped their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. TD Cowen cut their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Barclays boosted their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a report on Thursday, October 31st. Finally, Oppenheimer cut their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Fourteen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average price target of $12.08.

Teladoc Health Stock Down 6.2 %

TDOC opened at $12.99 on Wednesday. The stock has a market cap of $2.24 billion, a price-to-earnings ratio of -2.25 and a beta of 1.05. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm’s fifty day moving average is $10.13 and its 200 day moving average is $9.20. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $21.74.

Insiders Place Their Bets

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.95% of the stock is owned by insiders.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. increased its stake in Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock worth $167,830,000 after purchasing an additional 1,029,829 shares during the period. Point72 Asset Management L.P. increased its stake in Teladoc Health by 57.8% in the 3rd quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after buying an additional 3,063,172 shares during the period. Geode Capital Management LLC increased its stake in Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock worth $36,042,000 after buying an additional 56,864 shares during the period. Charles Schwab Investment Management Inc. lifted its holdings in Teladoc Health by 18.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock valued at $22,213,000 after buying an additional 384,528 shares in the last quarter. Finally, Assenagon Asset Management S.A. purchased a new stake in Teladoc Health in the 3rd quarter valued at about $15,801,000. 76.82% of the stock is owned by institutional investors.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.